Ad
related to: best electrolyte for chemo patients with osteoporosis definitionperfectfaqs.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies: Hypercholesterolaemia, cataract, urinary retention, hypocalcaemia, osteonecrosis of the jaw and anaphylaxis. Gemtuzumab ozogamicin: IV: CD33 antibody that induces apoptosis of the tagged cell. Acute myeloid leukaemia
Patient characteristics: Certain patient-related factors can affect the development of clinical tumor lysis syndrome. These factors include elevated baseline serum creatinine , kidney failure , dehydration, and other issues affecting urinary flow or the acidity of urine.
Zoledronic acid is used to prevent bone fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. [10] It can also be used to treat hypercalcaemia of malignancy and can be helpful for treating pain from bone metastases. [11] It can be given at home rather than in hospital.
Electrochemotherapy (ECT [1]) is a type of chemotherapy that allows delivery of non-permeant drugs to the cell interior. It is based on the local application of short and intense electric pulses that transiently permeabilize the cell membrane, thus allowing transport of molecules otherwise not permitted by the membrane .
Electrolyte monitoring is important in the treatment of anorexia and bulimia. In science, electrolytes are one of the main components of electrochemical cells. [2] In clinical medicine, mentions of electrolytes usually refer metonymically to the ions, and (especially) to their concentrations (in blood, serum, urine, or other fluids). Thus ...
A supporting electrolyte, in electrochemistry, according to an IUPAC definition, [1] is an electrolyte containing chemical species that are not electroactive (within the range of potentials used) and which has an ionic strength and conductivity much larger than those due to the electroactive species added to the electrolyte.
The bone disease osteoporosis, which significantly increases the risk of fracture, is a serious health concern. As we age, the prevalence of osteoporosis increases—especially for women.
In June 2010, denosumab was approved by the FDA for use in postmenopausal women with risk of osteoporosis [38] under the brand name Prolia, [39] and in November 2010, as Xgeva for the prevention of skeleton-related events in people with bone metastases from solid tumors. [40] Denosumab is the first RANKL inhibitor to be approved by the FDA. [38]
Ad
related to: best electrolyte for chemo patients with osteoporosis definitionperfectfaqs.com has been visited by 1M+ users in the past month